Expression of mucins and cytokeratins in primary carcinomas of the digestive system

Modern Pathology

Volumn 16, Issue 5, 2003, Pages 403-410

  Lee, Min Jong ^a   Lee, Hye Seung ^a   Kim, Woo Ho ^a   Choi, Yunhee ^a   Yang, Mihi ^a  

^a Seoul National University College of Medicine   (South Korea)

Author keywords

Classification; Cytokeratin; Digestive system; Gastrointestinal neoplasm; Immunohistochemistry. Mucin

Indexed keywords

CYTOKERATIN; CYTOKERATIN 13; CYTOKERATIN 14; CYTOKERATIN 18; CYTOKERATIN 19; CYTOKERATIN 20; CYTOKERATIN 7; CYTOKERATIN 8; MONOCLONAL ANTIBODY; MUCIN; MUCIN 1; MUCIN 2; MUCIN 5AC; MUCIN 6; UNCLASSIFIED DRUG;

ADENOCARCINOMA; ANTIBODY DETECTION; APPENDIX CANCER; ARTICLE; BILE DUCT CANCER; CANCER CLASSIFICATION; CANCER LOCALIZATION; COLORECTAL CANCER; CONTROLLED STUDY; GASTROINTESTINAL CARCINOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; PANCREAS ADENOCARCINOMA; PREDICTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SMALL INTESTINE CANCER; STOMACH ADENOCARCINOMA;

ADENOCARCINOMA; CLUSTER ANALYSIS; DECISION TREES; DIGESTIVE SYSTEM NEOPLASMS; HUMANS; IMMUNOENZYME TECHNIQUES; KERATINS; MUCINS; PROTEIN ARRAY ANALYSIS; TISSUE EMBEDDING; TUMOR MARKERS, BIOLOGICAL;

EID: 0038146964     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.MP.0000067683.84284.66     Document Type: Article

References (27)

1. Hainsworth JD, Greco FA. Treatment of patients with cancer of unknown primary site. N Engl J Med 1993;329:257-63.
2. Tot T, Cyrokeratins 20 and 7 as biomarkers: usefulness in discriminating primary from metastatic adenocarcinoma. Eur J Cancer 2002;38:758-63.
3. Tot T. Adenocarcinoma metastatic to the liver. Cancer 1999; 85:171-7.
4. Maeda T, Kajiyama K, Adachi E, Takenaka K, Sugimachi K, Tsuneyoshi M. The expression of cytokeratins 7, 19, and 20 in primary and metastatic carcinomas of the liver. Mod Pathol 1996;9:901-9.
5. Ramaekers F, van Niekerk C, Poels L, Schaafsma E, Huijsmans A, Robben H, et al. Use of monoclonal antibodies to keratin 7 in the differential diagnosis of adenocarcinomas. Am J Pathol 1990;136:641-55.
6. Loy TS, Calaluce RD, Keeney GL. Cytokeratin immunostaining in differentiating primary ovarian carcinoma from metastatic colonic adenocarcinoma. Mod Pathol 1996;9:1040-4.
7. Rullier A, Le Bail B, Fawaz R, Blanc JF, Saric J, Bioulac-Sage P. Cytokeratin 7 and 20 expression in cholangiocarcinomas varies along the biliary tract but still differs from that in colorectal carcinoma metastasis. Am J Surg Pathol 2000;24:870-6.
8. Lee HS, Lee HK, Kim HS, Yang HK, Kim YI, Kim WH. MUC1, MUC2, MUC5AC, and MUC6 expressions in gastric carcinomas. Cancer 2001;92:1427-34.
9. Dekker J, Rossen JW, Buller HA, Einerhand AW. The MUC. family: an obituary. Trends Biochem Sci 2002;27:126-31.
10. Taylor KL, Mall AS, Barnard RA, Ho SB, Cruse JP. Immunohistochemical detection of gastric mucin in normal and disease states. Oncol res 1998;10:465-73.
11. Allen A, Hutton DA, Pearson JP. The MUC2 gene product: a human intestinal mucin. Int J Biochem Cell Biol 1998;30:797-801.
12. Corfield AP, Myerscough N, Longman R, Sylvester P, Arul S, Pignatelli M. Mucins and mucosal protection in the gastrointestinal tract: new prospects for mucins in the pathology of gastrointestinal disease. Gut 2000;47:589-94.
13. Sasaki M, Yamato T, Nakanuma Y, Ho SB, Kim YS. Expression of MUC2, MUCSAC and MUC6 apomucins in carcinoma, dysplasia and non-dysplastic epithelia of the gallbladder. Pathol Int 1999;49:38-44.
14. Moll R, Franke WW, Schiller DL, Geiger B, Krepler R. The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells. Cell 1982;31:11-24.
15. Ramaeker F, Van Niekerk C, Poels L, Schaafsma E, Huijsmans A, Robben H, et al. Use of monoclonal antibodies to keratin 7 in differential diagnosis of adenocarcinomas. Am J Pathol 1990;136:641-55.
16. Moll R, Lowe A, Laufer J, Franke WW. Cytokeratin 20 in human carcinomas: A new diagnostic marker detected by monoclonal antibodies. Am J Pathol 1992;140:427-47.
17. Botta MC, Ambu R, Liguori C, Van Eyken P, Pisanu A, Cabras A, et al. CK20 expression in the gastrointestinal tract of the embryo and fetus. Pathologica 2001;93:640-4.
18. Calnek D, Quaroni A. Changes in keratin expression during fetal and postnatal development of intestinal epithelial cells. Biochem J 1992;285:939-46.
19. Schussler MH, Skoudy A, Ramaekers F, Real FX. Intermediate filaments as differentiation markers of normal pancreas and pancreas cancer. Am J Pathol 1992;140:559-68.
20. Rubinstein E. Highly differentiated keratinizing squamous cell cancer of the cervix. Am J Surg Pathol 2002;26:676-86.
21. Chu P, Wu E, Weiss LM. Cytokeratin 7 and cytokeratin 20 expression in epithelial neoplasm. Mod Pathol 2000;13:962-72.
22. Duval JV, Savas L, Banner BF. Expression of cytokeratins 7 and 20 in carcinomas of extrahepatic biliary tract, pancreas, and gallbladder. Arch Pathol Lab Med 2000;124:1196-220.
23. Goel A, Gupta I, Joshi K. Immunohistochemical analysis of human embryos and fetuses: an insight into the mechanism of subversion of antigenic differentiation in neoplasia. Arch Pathol Lab Med 1997;121:719-23.
24. Reid CJ, Harris A. Developmental expression of mucin genes in the human gastrointestinal system. Gut 1998;42:220-6.
25. Nocito A, Kononen J, Kallioniemi OP, Sauter G. Tissue microarrays (TMAS) for high-throughput molecular pathology research. Int J Cancer 2001;94:1-5.
26. Bucher C, Torhorst J, Bubendorf L, Schraml P, Kononen J, Moch H. Tissue microarray ("tissue chips") for high-throughput cancer genetics: linking molecular changes to clinical endpoints. Am J Hum Genet 1999;65:A10.
27. Torhorst J, Bucher C, Kononen J, Haas P, Zuber M, Kochli OR, et al. Tissue microarrays for rapid linking of molecular changes to clinical endpoints. Am J Pathol 2001;159:2249-56.